[go: up one dir, main page]

Senokuchi et al., 1995 - Google Patents

New orally active serine protease inhibitors

Senokuchi et al., 1995

Document ID
100374248577267695
Author
Senokuchi K
Nakai H
Nakayama Y
Odagaki Y
Sakaki K
Kato M
Maruyama T
Miyazaki T
Ito H
Kamiyasu K
Kim S
Kawamura M
Hamanaka N
Publication year
Publication venue
Journal of medicinal chemistry

External Links

Snippet

, X= CF3CO2 (87%) a Reagent:(a) f-Bu0C0CH2P= 0 (Et0) 2, NaH, THE, 25 C, 0.5 h;(b) CF3COOH, anisóle, 25 C, 2 h;(c) SOCl2, reflux, 1 h;(d) lV-allylglycine ethyl ester, py, CH2C12, 5-25 C, 1 h;(e)¿ V-allylglycine fert-butyl ester, py, CH2C12, 5-25 C, 1 h;(f) …
Continue reading at pubs.acs.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link

Similar Documents

Publication Publication Date Title
US6388122B1 (en) Tryptase inhibitor and novel guanidino derivatives
US5543396A (en) Proline phosphonate derivatives
KR0143565B1 (en) P-substituted phenyl ester derivatives of pivalic acid, methods for their preparation and compositions comprising them.
US5288707A (en) Borolysine peptidomimetics
Senokuchi et al. New orally active serine protease inhibitors
EP0815123B1 (en) Beta-sheet mimetics and use thereof as protease inhibitors
SK82198A3 (en) Prodrugs of thrombin inhibitors
US4707490A (en) Anti-hypertensive agents
NO180196B (en) Analogous Process for Preparation of Therapeutically Active Amino and Nitro Containing Tricyclic Compounds
Bai et al. Structural requirements for the intestinal mucosal-cell peptide transporter: the need for N-terminal α-amino group
Angliker et al. Synthesis and properties of peptidyl derivatives of arginylfluoromethanes
US6235707B1 (en) Anticoagulant peptidyl-arginine aldehyde derivatives
WO1998028326A1 (en) Bicyclic thrombin inhibitors
WO1998028326A9 (en) Bicyclic thrombin inhibitors
RU2175327C2 (en) Derivatives of imidazo-[1,5-a]-pyridine as inhibitors of serine proteases and pharmaceutical composition
US6121241A (en) Anticoagulant peptide aldehyde derivatives
Tsunematsu et al. Synthesis and the stereoselective enzymatic hydrolysis of flurbiprofen-basic amino acid ethyl esters
Masaki et al. Inhibition of Achromobacter protease I by lysinal derivatives
TSUDA et al. Synthesis of tripeptide amide derivatives and examination of their inhibitory effect on human leukocyte elastase (HLE)
US5539123A (en) Low molecular weight thiocarbamates as inhibitors of elastase, uses and method of synthesis
Angliker et al. Pseudoarginine: synthesis and properties of derivatives of delta-(1-imidazolyl) norvaline
Hideaki et al. Synthesis and enzymatic hydrolysis of aspirin-basic amino acid ethyl esters
US9133194B2 (en) Cyclic tripeptide mimetics as plasmin inhibitors
NOCHI et al. Kinetic study on the mechanism of inhibition of trypsin and trypsin-like enzymes by p-guanidinobenzoate ester
Murakami et al. Piperastatin B: a new selective serine carboxypeptidase inhibitor from Streptomyces lavendofoliae MJ908-WF13